In stage III MSS patients who received adjuvant chemotherapy, high SLPI expression was significantly associated with increased disease-free survival (HRR 0.48, P-value 0.04, 95% confidence interval 0.23–0.98, Fig. 3d). The gene discussed is SLPI; the disease is Marinesco-Sjogren syndrome.